Literature DB >> 35071442

Endotracheal intubation-still the gold standard in out-of-hospital cardiac arrest airway management?

Jonathan Teng Fai Loke1, Seth En Teoh2, John J Y Zhang3, Yoshio Masuda2.   

Abstract

Entities:  

Year:  2021        PMID: 35071442      PMCID: PMC8743700          DOI: 10.21037/atm-21-4668

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
We read with great interest the article written by Yang et al. titled “Comparing the efficacy of bag-valve mask, endotracheal intubation, and laryngeal mask airway for subjects with out-of-hospital cardiac arrest: an indirect meta-analysis” (1). The authors of the study must be congratulated for their efforts in performing an indirect meta-analysis of 13 studies to compare the outcomes of bag-valve mask (BVM), laryngeal mask airway (LMA), and endotracheal intubation (ETI). Outcome measures used were return of spontaneous circulation (ROSC) and the survival rate to admission or discharge. Approximately 300,000 persons in the United States alone experience an out-of-hospital cardiac arrest (OHCA) each year with a mortality of approximately 92% (2). This review is made even more timely by the current unprecedented global health crisis caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). A recent systematic review identified that there has been a 120% increase in the incidence of OHCA since the pandemic, with an increase in mortality and supraglottic airway usage (3). Therefore, this article provides invaluable insights in the current conversation for OHCA management during the pandemic. Despite the importance of effective airway management in the treatment of patients with OHCA, there is a paucity of available data on the topic, including limited high-quality Randomized Controlled Trial (RCT) data comparing the efficacy of various techniques in airway management. Randomized trials have proven to be the gold standard in analysing causal relationships as the act of randomisation and concealment of allocation eradicates inherent biases that might exist in other study designs (4). Equipoise between the various techniques have led to calls for more and larger RCTs comparing the use of BVM, LMA, and ET in the context of OHCA, to determine the most optimal device for airway management. Of the 13 studies included by Yang et al., three studies were randomized while the rest were observational in nature. We conducted a sensitivity analysis to compare the findings of the randomized studies against the findings by Yang et al., to identify any incongruity in the findings. Our analysis found that there were differing results for ROSC and survival to discharge when comparing BMV to LMA as compared to the values that were presented by Yang et al. On inspection of the randomized studies by Benger et al. and Fiala et al., we found no statistically significant difference when comparing BVM and LMA in the outcome of ROSC (RR =1.00, 95% CI, 0.75–1.33; I2=0%, P=1.00) () (5,6). Yang et al., however, found that there was a significant difference between LMA and BVM (RR =0.84%, 95% CI, 0.57–1.24; I2=94.8%, P<0.001) (1).
Figure 1

Forest plots of BVM and LMA for the outcome of ROSC and for the outcome of survival to discharge. (A) Forest plot comparing BVM and LMA for the outcome of ROSC; (B) Forest plot comparing BVM and LMA for the outcome of survival to discharge. BVM, bag-valve-mask; LMA, laryngeal mask airway; ROSC, return of spontaneous circulation.

Forest plots of BVM and LMA for the outcome of ROSC and for the outcome of survival to discharge. (A) Forest plot comparing BVM and LMA for the outcome of ROSC; (B) Forest plot comparing BVM and LMA for the outcome of survival to discharge. BVM, bag-valve-mask; LMA, laryngeal mask airway; ROSC, return of spontaneous circulation. Further discrepancies were noted in survival to discharge when comparing BVM with LMA for the randomized studies. Our results revealed no significant difference between BVM and LMA (RR =1.11, 95% CI, 0.59–2.11; I2=0%, P=0.74). () This is contrary to the results in the original study, whereby BVM was shown to be significantly better than LMA (RR =0.61; 95% CI, 0.38–0.98; I2=79.4%, P<0.001) (1). The study by Ono et al. was intentionally excluded from the results in as the use of the laryngeal tube, an extra glottic airway device, was classified under ETI instead (7,8). However, these values should be interpreted with caution as the two randomized studies listed had relatively smaller sample sizes as compared to the non-randomized counterparts. This can be attributable either to the nature of the study; as a direct consequence of randomization, or due to limitations such as number of eligible participants that fulfil the inclusion criteria, the amount of time available, and the budget allocated for the trial. Nonetheless, there are benefits to randomized trials as it allows for the comparison of cause and effect relationships between interventions and outcomes (9). Randomisation also prevents any priori knowledge of group assignments and balances participant characteristics between the groups, therefore reducing any selection biases that might skew the results and allowing for any attribution of differences in outcomes to the intervention (10). Besides the aforementioned limitations with RCTs, it is essential to acknowledge the challenges that exist especially in the context of Emergency Medicine, due to the possible ethical implications and the nature of the trial. This is particularly so with OHCA due to its unpredictable nature, making it impossible to gain the consent of patients prior to enrolment and implementation of intervention. Moreover, due to the urgency and variability in the presentation of eligible patients, randomization by patients might lead to delays in care processes and is not only impractical but potentially unethical. Finally, there also exists a risk of residual confounding bias as numerous compounding variables such as the ventilation rate, duration of chest compression interruption for the insertion of airway adjunct, as well as other interventions that might have been performed either on-site or in-hospital, might have influences on the outcome which cannot be accounted for. In conclusion, we acknowledge that airway management is of paramount importance in the treatment of OHCA. Although ETI has long been considered the gold standard of airway management, with the advent of alternative airway devices, there has been a recent paradigm shift regarding the most effective device for airway control. Currently, evidence on this matter remains scarce and there is a pertinent need to conduct further large scale RCTs, in order to gather more data on the efficacy of each device on the outcomes of OHCA. The article’s supplementary files as
  10 in total

1.  Should laryngeal tubes or masks be used for out-of-hospital cardiac arrest patients?

Authors:  Yuichi Ono; Mineji Hayakawa; Kunihiko Maekawa; Asumi Mizugaki; Kenichi Katabami; Takeshi Wada; Atsushi Sawamura; Satoshi Gando
Journal:  Am J Emerg Med       Date:  2015-07-29       Impact factor: 2.469

2.  Randomized controlled trial: the gold standard or an unobtainable fallacy?

Authors:  Lars Bondemark; Sabine Ruf
Journal:  Eur J Orthod       Date:  2015-07-01       Impact factor: 3.075

Review 3.  The laryngeal tube.

Authors:  T Asai; K Shingu
Journal:  Br J Anaesth       Date:  2005-12       Impact factor: 9.166

4.  Out-of-hospital cardiac arrest surveillance --- Cardiac Arrest Registry to Enhance Survival (CARES), United States, October 1, 2005--December 31, 2010.

Authors:  Bryan McNally; Rachel Robb; Monica Mehta; Kimberly Vellano; Amy L Valderrama; Paula W Yoon; Comilla Sasson; Allison Crouch; Amanda Bray Perez; Robert Merritt; Arthur Kellermann
Journal:  MMWR Surveill Summ       Date:  2011-07-29

5.  Randomised controlled trials - the gold standard for effectiveness research: Study design: randomised controlled trials.

Authors:  Eduardo Hariton; Joseph J Locascio
Journal:  BJOG       Date:  2018-06-19       Impact factor: 6.531

6.  Comparing the efficacy of bag-valve mask, endotracheal intubation, and laryngeal mask airway for subjects with out-of-hospital cardiac arrest: an indirect meta-analysis.

Authors:  Zhanzheng Yang; Hengrui Liang; Jiaying Li; Shuxian Qiu; Zhuosen He; Jinyin Li; Zanfeng Cao; Ping Yan; Qing Liang; Liangbo Zeng; Rong Liu; Zijing Liang
Journal:  Ann Transl Med       Date:  2019-06

7.  Randomised comparison of the effectiveness of the laryngeal mask airway supreme, i-gel and current practice in the initial airway management of out of hospital cardiac arrest: a feasibility study.

Authors:  J Benger; D Coates; S Davies; R Greenwood; J Nolan; M Rhys; M Thomas; S Voss
Journal:  Br J Anaesth       Date:  2016-02       Impact factor: 9.166

8.  An overview of randomization techniques: An unbiased assessment of outcome in clinical research.

Authors:  Kp Suresh
Journal:  J Hum Reprod Sci       Date:  2011-01

Review 9.  Incidence and outcome of out-of-hospital cardiac arrests in the COVID-19 era: A systematic review and meta-analysis.

Authors:  Zheng Jie Lim; Mallikarjuna Ponnapa Reddy; Afsana Afroz; Baki Billah; Kiran Shekar; Ashwin Subramaniam
Journal:  Resuscitation       Date:  2020-11-01       Impact factor: 5.262

10.  EMT-led laryngeal tube vs. face-mask ventilation during cardiopulmonary resuscitation - a multicenter prospective randomized trial.

Authors:  Anna Fiala; Wolfgang Lederer; Agnes Neumayr; Tamara Egger; Sabrina Neururer; Ernst Toferer; Michael Baubin; Peter Paal
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2017-10-26       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.